Elsevier

Clinical Biochemistry

Volume 39, Issue 10, October 2006, Pages 1007-1015
Clinical Biochemistry

Total plasma homocysteine values among elderly subjects: Findings from the Maracaibo Aging Study

https://doi.org/10.1016/j.clinbiochem.2006.07.005Get rights and content

Abstract

Objectives:

The present study generated baseline data for total homocysteine (tHcy) in elderly Caribbeans of Hispanic ancestry, residing in Venezuela, their country of origin.

Design and methods:

2106 participants in the Maracaibo Aging Study (MAS), older than 55 years, underwent standardized clinical and laboratory assessments, including measurement of plasma tHcy levels, folate, and vitamin B12 in fasting samples.

Results:

tHcy concentration in the healthy, normative group ranged from 4.1 to 31.8 μmol/L, with a median of 11.5 ± 4.7 μmol/L. tHcy level increased with age, was significantly higher in men than in women, and exhibited inverse correlations with folate and vitamin B12.

Conclusions:

tHcy levels of the MAS participants were generally higher than levels previously reported for community-dwelling elderly populations from other countries. The normative centile curves for tHcy can be used in disease risk analysis for this population, and possibly for other Hispanic populations residing in the Caribbean.

Introduction

Homocysteine (Hcy) is an amino acid derived from methionine demethylation. To reconstitute methionine, Hcy can acquire a methyl group from methyltetrahydrofolate in a reaction catalyzed by vitamin B12-dependent methyltransferase [1]. Age and gender affect the plasma levels of Hcy and previous studies have shown that values of plasma total Hcy (tHcy) increase throughout life, and that men exhibit higher values than women [2], [3]. Diet, micronutrient supplementation, smoking, and alcohol consumption may further influence tHcy levels [4], [5], [6], [7]. Although it has been suggested that the Hispanic populations exhibit lower tHcy levels than non-Hispanic populations [8], [9], [10], [11], there is insufficient information on tHcy from different ethnic groups, particularly elderly Hispanics, to test this hypothesis. To date, no tHcy values have been published for elderly Hispanics residing in a developing country. Given differences in nutrition and other lifestyle factors, Hcy levels for these individuals are likely to differ from levels of elderly Hispanics living in developed countries.

High plasma tHcy level constitutes a risk factor for several unfavorable conditions common among elderly people, including cardiovascular diseases [12], [13], [14], [15], [16], [17], Alzheimer's disease [18], and colon cancer [19]. To classify an individual as at risk for a specific disease using a laboratory parameter, it is necessary to determine the physiological range of that parameter, and the range for individuals with the disease [20].

Availability of appropriate normative data for elderly populations is critical to overcoming the current uncertainty in using tHcy levels to classify an older individual as at risk, and for treatment planning and outcome measurement. Although previous studies measured tHcy levels among elderly free of disease [21], [22], [23], [24], no study has provided baseline information about tHcy levels in a Caribbean population of Hispanic descent, residing in their country of origin.

The present work took advantage of an ongoing study of elderly people living in an urban community in Maracaibo, Venezuela, to determine the distribution of tHcy values among subjects older than 55 years. Healthy individuals in this population were used to generate normative tHcy values. The distribution of tHcy values was also determined for a reference sample that exhibited optimal levels of folate and vitamin B12.

Section snippets

The Maracaibo Aging Study population

Subjects included in this study were participants in the Maracaibo Aging Study (MAS), a population-based, longitudinal study of age-related conditions that took place in Santa Lucia county, near downtown Maracaibo, Venezuela [25]. Santa Lucia contains both traditional houses and recently built, high-rise buildings, and is crossed by important thoroughfares. All available information indicates that the Santa Lucia population does not differ significantly from the rest of the population of

Characteristics of the entire MAS population

The age of the 2438 participants of the MAS who underwent full clinical assessment [40] ranged from 55 to 101 years (Table 1). Men constituted 33.2% of the sample, and were slightly, but significantly older than women (67.9 and 66.4 years, respectively; Mann–Whitney U test, p < 0.001). Health status of the participants was heterogeneous, ranging from healthy, self-sufficient persons to bed-ridden individuals.

Characteristics of the normative and reference groups

The normative group of healthy individuals was selected by review of the overall MAS

Discussion

The present study provides the first report of tHcy values for a population of elderly Hispanic Caribbeans, residing in their native country. The distribution of normative tHcy values presented herein provides baseline data that can be compared to tHcy values of individuals with specific medical disorders or risk levels to evaluate plasma tHcy as a diagnostic tool. The age- and gender-specific distributions can also be used to determine if the plasma tHcy of an apparently healthy individual is

Acknowledgments

The authors thank the staff of the Maracaibo Aging Study, in particular, Walevska Fulcado, Suria Hassani, and Belinda Villamizar for taking blood samples and processing homocysteine, folate, and vitamin B12, and Mallira Rodriguez for managing the database. We thank Sonia Pineda and Maria Zenaida Castellano for contacting the subjects; Maria del Carmen Nava, Carlos Chavez, Ida Ojeda, and Ledys Mata for clinical assessments; and Lenys Araujo for preclinical assistance. Thanks also go to Dr.

References (61)

  • I. Martin et al.

    Folate status and a new repletion cut-off value in a group of healthy Majorcan women

    Clin. Nutr.

    (2003)
  • A. Araki et al.

    Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection

    J. Chromatogr.

    (1987)
  • S.M. Saw et al.

    Genetic, dietary, and other lifestyle determinants of plasma homocysteine concentrations in middle-aged and older Chinese men and women in Singapore

    Am. J. Clin. Nutr.

    (2001)
  • M. Wolters et al.

    B vitamin status and concentrations of homocysteine and methylmalonic acid in elderly German women

    Am. J. Clin. Nutr.

    (2003)
  • O. Nygard et al.

    Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study

    Am. J. Clin. Nutr.

    (1998)
  • E.H. Mizrahi et al.

    Plasma homocysteine, vitamin B12 and folate in Alzheimer's patients and healthy Arabs in Israel

    J. Neurol. Sci.

    (2004)
  • Y. Moriyama et al.

    Effects of serum B vitamins on elevated plasma homocysteine levels associated with the mutation of methylenetetrahydrofolate reductase gene in Japanese

    Atherosclerosis

    (2002)
  • G.D. Lundberg

    How clinicians should use the diagnostic laboratory in a changing medical world

    Clin. Chim. Acta

    (1999)
  • J.D. Finkelstein

    The metabolism of homocysteine: pathways and regulation

    Eur. J. Pediatr.

    (1998)
  • R. Gillum

    Distribution of serum total homocysteine and its association with diabetes and cardiovascular risk factors of the insulin resistance syndrome in Mexican American men: the Third National Health and Nutrition Examination Survey

    Nutr. J.

    (2003)
  • H. Refsum et al.

    Facts and recommendations about total homocysteine determinations: an expert opinion

    Clin. Chem.

    (2004)
  • O. Nygard et al.

    Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study

    JAMA

    (1995)
  • P.M. Ueland et al.

    The Hordaland Homocysteine Studies

    Lipids

    (2001)
  • V. Ganji et al.

    Serum total homocysteine concentration determinants in non-Hispanic White, non-Hispanic Black, and Mexican-American populations of the United States

    Ethn. Dis.

    (2004)
  • R.D. Lindeman et al.

    Serum homocysteine concentrations and their relation to serum folate and vitamin B12 concentrations and coronary artery disease prevalence in an urban, bi-ethnic community

    Ethn. Dis.

    (2003)
  • R. Clarke et al.

    Hyperhomocysteinemia: an independent risk factor for vascular disease

    N. Engl. J. Med.

    (1991)
  • O. Nygard et al.

    Total homocysteine and cardiovascular disease

    J. Intern. Med.

    (1999)
  • M.J. Stampfer

    Homocysteine levels and cardiovascular disease

    Am. Fam. Phys.

    (1997)
  • L. Parnetti et al.

    Role of homocysteine in age-related vascular and non-vascular diseases

    Aging (Milano)

    (1997)
  • S. Seshadri et al.

    Plasma homocysteine as a risk factor for dementia and Alzheimer's disease

    N. Engl. J. Med.

    (2002)
  • Cited by (15)

    • Determinants of hyperhomocysteinemia in healthy and hypertensive subjects: A population-based study and systematic review

      2017, Clinical Nutrition
      Citation Excerpt :

      The main characteristics of the included studies are shown in Tables 3 and 4. Subjects were ethnically diverse, and the studies were conducted in North America [23–28], Europe [8,29–62], Asia [9,63–87], Africa [88,89], and Australia [90]. The correlates of Hcy were shown in Table 4.

    • Homocysteine induced SH-SY5Y apoptosis through activation of NADPH oxidase in U251MG cells

      2012, Neuroscience Research
      Citation Excerpt :

      Plasma Hcy concentrations are typically low as Hcy is easily converted to methionine or cystathionine in the liver or kidney. Nevertheless, insufficient intake of folate, vitamin B12, or vitamin B6 leads to hyperhomocysteinemia (Mason and Miller, 1992; Ubbink et al., 1993), while ageing is also an important factor (Molero et al., 2006). Furthermore, single nucleotide polymorphism of 5,10-methlyenetetrahydrofolate reductase (C677T) is a well-established cause of hyperhomocysteinemia (Almawi et al., 2004).

    • Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors

      2008, The Lancet Neurology
      Citation Excerpt :

      Vascular disease-controlling medications, such as antihypertensives and statins, might not be protective.173,174 The most cost-effective way to prevent dementia might be through dietary or lifestyle interventions in communities at variable risk of cardiovascular disease,175 such as the Yoruba,176 northern Indians,177 Venezuelans,178 and Wadi Ara Arabs.179 Studies examining nutritional risk, which often rely on self-reports, are fraught with difficulties and should be cautiously interpreted.

    View all citing articles on Scopus
    View full text